These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12874535)

  • 21. Sample size re-estimation in group-sequential response-adaptive clinical trials.
    Morgan CC
    Stat Med; 2003 Dec; 22(24):3843-57. PubMed ID: 14673942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis of temporomandibular disorders according to RDC/TMD axis I findings, a multicenter Italian study.
    Manfredini D; Segù M; Bertacci A; Binotti G; Bosco M
    Minerva Stomatol; 2004; 53(7-8):429-38. PubMed ID: 15278021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increasing the sample size when the unblinded interim result is promising.
    Chen YH; DeMets DL; Lan KK
    Stat Med; 2004 Apr; 23(7):1023-38. PubMed ID: 15057876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inadequate statistical power of negative clinical trials in urological literature.
    Breau RH; Carnat TA; Gaboury I
    J Urol; 2006 Jul; 176(1):263-6. PubMed ID: 16753417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calculation of sample size in survival trials: the impact of informative noncompliance.
    Jiang Q; Snapinn S; Iglewicz B
    Biometrics; 2004 Sep; 60(3):800-6. PubMed ID: 15339304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statistical power and sample size estimation for headache research: an overview and power calculation tools.
    Houle TT; Penzien DB; Houle CK
    Headache; 2005 May; 45(5):414-8. PubMed ID: 15953257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Some design issues of strata-matched non-randomized studies with survival outcomes.
    Mazumdar M; Tu D; Zhou XK
    Stat Med; 2006 Dec; 25(23):3949-59. PubMed ID: 16596571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the statistical power for multiple tests: a case study.
    Yeo A; Qu Y
    Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of signs and symptoms of temporomandibular disorders in an urban and rural German population: results of a population-based Study of Health in Pomerania.
    Gesch D; Bernhardt O; Alte D; Schwahn C; Kocher T; John U; Hensel E
    Quintessence Int; 2004 Feb; 35(2):143-50. PubMed ID: 15000638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Types of studies, power of study and choice of test].
    Hren D; Lukić KI
    Acta Med Croatica; 2006; 60 Suppl 1():47-62. PubMed ID: 16526307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of adaptive sample size adjustment with respect to stopping criteria and time of interim analysis.
    Jahn-Eimermacher A; Hommel G
    Stat Med; 2007 Mar; 26(7):1450-61. PubMed ID: 16900553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sample sizes for clinical trials with normal data.
    Julious SA
    Stat Med; 2004 Jun; 23(12):1921-86. PubMed ID: 15195324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis and importance of statistical power and sample size in empirical scientific research].
    Klimek KM
    Wiad Lek; 2008; 61(7-9):211-5. PubMed ID: 19172834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sample size and the probability of a successful trial.
    Chuang-Stein C
    Pharm Stat; 2006; 5(4):305-9. PubMed ID: 17128428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Group sequential t-test for clinical trials with small sample sizes across stages.
    Shao J; Feng H
    Contemp Clin Trials; 2007 Sep; 28(5):563-71. PubMed ID: 17434814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal spending functions for asymmetric group sequential designs.
    Anderson KM
    Biom J; 2007 Jun; 49(3):337-45. PubMed ID: 17623339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding statistical analysis in the surgical literature: some key concepts.
    Young J
    ANZ J Surg; 2009 May; 79(5):398-403. PubMed ID: 19566528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sample size calculations.
    Noordzij M; Dekker FW; Zoccali C; Jager KJ
    Nephron Clin Pract; 2011; 118(4):c319-23. PubMed ID: 21293154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Power analyses for longitudinal trials and other clustered designs.
    Tu XM; Kowalski J; Zhang J; Lynch KG; Crits-Christoph P
    Stat Med; 2004 Sep; 23(18):2799-815. PubMed ID: 15344187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing the validity of clinical trials.
    Akobeng AK
    J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):277-82. PubMed ID: 18728521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.